219 related articles for article (PubMed ID: 38357002)
21. TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma model.
Moukengue B; Brown HK; Charrier C; Battaglia S; Baud'huin M; Quillard T; Pham TM; Pateras IS; Gorgoulis VG; Helleday T; Heymann D; Berglund UW; Ory B; Lamoureux F
EBioMedicine; 2020 Mar; 53():102704. PubMed ID: 32151797
[TBL] [Abstract][Full Text] [Related]
22. OGG1 co-inhibition antagonizes the tumor-inhibitory effects of targeting MTH1.
Zhang L; Misiara L; Samaranayake GJ; Sharma N; Nguyen DM; Tahara YK; Kool ET; Rai P
Redox Biol; 2021 Apr; 40():101848. PubMed ID: 33450725
[TBL] [Abstract][Full Text] [Related]
23. Mutational specificity of mice defective in the MTH1 and/or the MSH2 genes.
Egashira A; Yamauchi K; Yoshiyama K; Kawate H; Katsuki M; Sekiguchi M; Sugimachi K; Maki H; Tsuzuki T
DNA Repair (Amst); 2002 Nov; 1(11):881-93. PubMed ID: 12531017
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of Oxidized Nucleotide Sanitation By TH1579 and Conventional Chemotherapy Cooperatively Enhance Oxidative DNA Damage and Survival in AML.
Centio A; Estruch M; Reckzeh K; Sanjiv K; Vittori C; Engelhard S; Warpman Berglund U; Helleday T; Theilgaard-Mönch K
Mol Cancer Ther; 2022 May; 21(5):703-714. PubMed ID: 35247918
[TBL] [Abstract][Full Text] [Related]
25. MutT Homolog1 has multifaceted role in glioma and is under the apparent orchestration by Hypoxia Inducible factor1 alpha.
Bhavya B; Easwer HV; Vilanilam GC; Anand CR; Sreelakshmi K; Urulangodi M; Rajalakshmi P; Neena I; Padmakrishnan CJ; Menon GR; Krishnakumar K; Deepti AN; Gopala S
Life Sci; 2021 Jan; 264():118673. PubMed ID: 33130078
[TBL] [Abstract][Full Text] [Related]
26. Targeting MutT Homolog 1 (MTH1) for Breast Cancer Suppression by Using a Novel MTH1 Inhibitor MA-24 with Tumor-Selective Toxicity.
Kang N; Ma J; Hu Y; Di R; Wang L; Zhang X; Lai Y; Liu Y
Pharmaceuticals (Basel); 2024 Feb; 17(3):. PubMed ID: 38543077
[TBL] [Abstract][Full Text] [Related]
27. The high expression of MTH1 and NUDT5 promotes tumor metastasis and indicates a poor prognosis in patients with non-small-cell lung cancer.
Li DN; Yang CC; Li J; Ou Yang QG; Zeng LT; Fan GQ; Liu TH; Tian XY; Wang JJ; Zhang H; Dai DP; Cui J; Cai JP
Biochim Biophys Acta Mol Cell Res; 2021 Jan; 1868(1):118895. PubMed ID: 33096144
[TBL] [Abstract][Full Text] [Related]
28. MutT Homolog 1 Inhibitor Karonudib Attenuates Autoimmune Hepatitis by Inhibiting DNA Repair in Activated T Cells.
Chen Y; Hua X; Huang B; Karsten S; You Z; Li B; Li Y; Li Y; Liang J; Zhang J; Wei Y; Chen R; Lyu Z; Xiao X; Lian M; Wei J; Fang J; Miao Q; Wang Q; Berglung UW; Tang R; Helleday T; Ma X
Hepatol Commun; 2022 May; 6(5):1016-1031. PubMed ID: 34894107
[TBL] [Abstract][Full Text] [Related]
29. Investigation of micronucleus induction in MTH1 knockdown cells exposed to UVA, UVB or UVC.
Fotouhi A; Cornella N; Ramezani M; Wojcik A; Haghdoost S
Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():161-5. PubMed ID: 26520386
[TBL] [Abstract][Full Text] [Related]
30. The Existence of MTH1-independent 8-oxodGTPase Activity in Cancer Cells as a Compensatory Mechanism against On-target Effects of MTH1 Inhibitors.
Samaranayake GJ; Troccoli CI; Zhang L; Huynh M; Jayaraj CJ; Ji D; McPherson L; Onishi Y; Nguyen DM; Robbins DJ; Karbaschi M; Cooke MS; Barrientos A; Kool ET; Rai P
Mol Cancer Ther; 2020 Feb; 19(2):432-446. PubMed ID: 31744893
[TBL] [Abstract][Full Text] [Related]
31. MutT homologue 1 (MTH1) removes N6-methyl-dATP from the dNTP pool.
Scaletti ER; Vallin KS; Bräutigam L; Sarno A; Warpman Berglund U; Helleday T; Stenmark P; Jemth AS
J Biol Chem; 2020 Apr; 295(15):4761-4772. PubMed ID: 32144205
[TBL] [Abstract][Full Text] [Related]
32. MutT homologue 1 (MTH1) catalyzes the hydrolysis of mutagenic O6-methyl-dGTP.
Jemth AS; Gustafsson R; Bräutigam L; Henriksson L; Vallin KSA; Sarno A; Almlöf I; Homan E; Rasti A; Warpman Berglund U; Stenmark P; Helleday T
Nucleic Acids Res; 2018 Nov; 46(20):10888-10904. PubMed ID: 30304478
[TBL] [Abstract][Full Text] [Related]
33. Discovery of a new class of MTH1 inhibitor by X-ray crystallographic screening.
Yokoyama T; Kitakami R; Mizuguchi M
Eur J Med Chem; 2019 Apr; 167():153-160. PubMed ID: 30771603
[TBL] [Abstract][Full Text] [Related]
34. Birth of MTH1 as a therapeutic target for glioblastoma: MTH1 is indispensable for gliomatumorigenesis.
Tu Y; Wang Z; Wang X; Yang H; Zhang P; Johnson M; Liu N; Liu H; Jin W; Zhang Y; Cui D
Am J Transl Res; 2016; 8(6):2803-11. PubMed ID: 27398163
[TBL] [Abstract][Full Text] [Related]
35. Crystal Structures and Inhibitor Interactions of Mouse and Dog MTH1 Reveal Species-Specific Differences in Affinity.
Narwal M; Jemth AS; Gustafsson R; Almlöf I; Warpman Berglund U; Helleday T; Stenmark P
Biochemistry; 2018 Feb; 57(5):593-603. PubMed ID: 29281266
[TBL] [Abstract][Full Text] [Related]
36. Mitotic MTH1 Inhibitors in Treatment of Cancer.
Helleday T
Cancer Treat Res; 2023; 186():223-237. PubMed ID: 37978139
[TBL] [Abstract][Full Text] [Related]
37. Human Mut T Homolog 1 (MTH1): a roadblock for the tumor-suppressive effects of oncogenic RAS-induced ROS.
Rai P
Small GTPases; 2012; 3(2):120-5. PubMed ID: 22790201
[TBL] [Abstract][Full Text] [Related]
38. MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid Leukemia.
Sanjiv K; Calderón-Montaño JM; Pham TM; Erkers T; Tsuber V; Almlöf I; Höglund A; Heshmati Y; Seashore-Ludlow B; Nagesh Danda A; Gad H; Wiita E; Göktürk C; Rasti A; Friedrich S; Centio A; Estruch M; Våtsveen TK; Struyf N; Visnes T; Scobie M; Koolmeister T; Henriksson M; Wallner O; Sandvall T; Lehmann S; Theilgaard-Mönch K; Garnett MJ; Östling P; Walfridsson J; Helleday T; Warpman Berglund U
Cancer Res; 2021 Nov; 81(22):5733-5744. PubMed ID: 34593524
[TBL] [Abstract][Full Text] [Related]
39. MTH1 expression is required for effective transformation by oncogenic HRAS.
Giribaldi MG; Munoz A; Halvorsen K; Patel A; Rai P
Oncotarget; 2015 May; 6(13):11519-29. PubMed ID: 25893378
[TBL] [Abstract][Full Text] [Related]
40. Molecular genetics and structural biology of human MutT homolog, MTH1.
Nakabeppu Y
Mutat Res; 2001 Jun; 477(1-2):59-70. PubMed ID: 11376687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
